Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS9950 in Virologically Suppressed Chronic Hepatitis B
NCT05905458Phase 2Completed
- Sponsor
- Chengdu Suncadia Pharmaceuticals
- Start
- Jul 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS9950 in Chronic Hepatitis B (CHB), sponsored by Chengdu Suncadia Pharmaceuticals. Started Jul 2023; status: completed.
02
Drugs
HRS9950
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05905458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05905458.